We conducted clinical trials in multiple centers and obtained clinical trial data from Chinese patients. We also maintained frequent and thorough communication with regulatory agencies and actively engaged with key opinion leaders.

draft a statement in english 1在多个中心开展试验得到中国患者临床试验数据;2与监管机构的频繁并充分沟通;3核心KOL的积极沟通

原文地址: https://www.cveoy.top/t/topic/6bz 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录